![Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market - Clinical Trials Arena Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2020/11/Glenmark.jpg)
Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market - Clinical Trials Arena
![Köp Risperidone Teva GmbH Pulver och vätska till injektionsvätska, depotsuspension 37,5 mg Risperidon 1 styck på Kronans Apotek | Kronans Apotek Köp Risperidone Teva GmbH Pulver och vätska till injektionsvätska, depotsuspension 37,5 mg Risperidon 1 styck på Kronans Apotek | Kronans Apotek](https://www.kronansapotek.se/k2/images/138728/large/0.jpg)
Köp Risperidone Teva GmbH Pulver och vätska till injektionsvätska, depotsuspension 37,5 mg Risperidon 1 styck på Kronans Apotek | Kronans Apotek
![FDA declines to approve Teva-MedinCell's risperidone injection for treating schizophrenia | Seeking Alpha FDA declines to approve Teva-MedinCell's risperidone injection for treating schizophrenia | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1320998287/image_1320998287.jpg?io=getty-c-crop-4-3)
FDA declines to approve Teva-MedinCell's risperidone injection for treating schizophrenia | Seeking Alpha
![FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults](https://www.drugs.com/images/pills/custom/pill34469-1/uzedy.jpeg)
FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
Risperidone "Teva GmbH" Teva GmbH pulver og solvens til depotinjektionsvæske, suspension 25 mg, 37,5 mg og 50 mg
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults
![FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults-CliniExpert FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults-CliniExpert](https://www.cliniexpert.com/attachment/20230506/0e8eb63dc3ba43779ba7169282220946.jpg)
FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults-CliniExpert
![These highlights do not include all the information needed to use UZEDY™ safely and effectively. See full prescribing information for UZEDY. UZEDY ( risperidone) extended-release injectable suspension, for subcutaneous use Initial U.S. Approval: These highlights do not include all the information needed to use UZEDY™ safely and effectively. See full prescribing information for UZEDY. UZEDY ( risperidone) extended-release injectable suspension, for subcutaneous use Initial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=uzedy-risperidone-er-inj-susp-n213586-26.jpg&id=709231)